samedi 14 mai 2011

Press review (May 14, 2011) – Revue de presse (14 mai 2011)

Chemo Combo May Help Stave Off Pancreatic Cancer Death
A four-drug chemotherapy regimen for deadly pancreatic cancer nearly doubled patients' survival time compared to standard chemotherapy, a new study suggests.
By Maureen Salamon. In U.S. News & World Report

Selenium doesn't prevent cancer: report
There is no convincing evidence that taking high doses of selenium -- a popular dietary supplement -- can prevent cancer, according to a new review.
By Genevra Pittman. Reuters

Genetic Test Shows Promise in Guiding Breast Cancer Care
Preliminary study suggests it could predict whether or not a patient will benefit from treatment.
By Amanda Gardner. In U.S. News & World Report

Five cups of coffee a day could protect against breast cancer
Women who drink coffee could be protecting themselves against an aggressive form of breast cancer, research suggests.
Those who regularly enjoy the hot drink are far less likely to develop oestrogen-receptor negative breast cancer – particularly if they drink five cups or more a day
In Daily Mail

Breast cancer awareness needed in Lebanon
In Lebanon it is also the most common form of cancer for women, which is why experts are advocating the launch of an awareness campaign.
By Alexandra Taylor. In Daily Star - Lebanon  

Chronic use of acetaminophen tied to blood cancers: study
Chronic users of the painkiller acetaminophen are at a slightly increased risk for blood cancers, according to a U.S. study.
By Elaine Lies. Reuters

Yale researchers explain why cancer 'smart drugs' may not be so smart
Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients.
In EurekAlert (press release)

Roche files skin cancer drug in USA and Europe
Roche is seeking approvals for vemurafenib, which the firm says is "the first personalised investigational medicine to have shown a significant overall survival benefit in metastatic melanoma". Specifically, Roche has filed vemurafenib with the US Food and Drug Administration and the European Medicines Agency for approval for people with BRAF V600 mutation-positive metastatic melanoma.
By Kevin Grogan. In Pharma Times

Une grande consommation de café réduirait les risques de cancer du sein 
Cinq tasses de café par jour réduiraient considérablement les risques de cancer du sein. Après avoir analysé les données de 6 000 femmes, les chercheurs de l’Institut Karolinska à Stockholm mentionnent que celles qui consomment du café quotidiennement ont moins de risques de développer les formes agressives du cancer du sein, en particulier si elles boivent cinq tasses et plus par jour.
Dans Canoë

Le radis, pour donner du piquant à la lutte au cancer 
Très apprécié pour sa texture croquante et son goût légèrement piquant, le radis est l'un des légumes les plus souvent cultivés dans nos potagers locaux. Il s'agit d'une tradition excellente pour la santé, car ce légume délicieux contient plusieurs molécules dotées de propriétés anticancéreuses.
Dans Canoë

Aucun commentaire:

Enregistrer un commentaire